• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

Cleveland Research Has Fitbit Shareholders Running

The highly elusive Cleveland Research is putting the screws to Fitbit.
By ANDERS KEITZ Oct 07, 2016 | 02:15 PM EDT
Stocks quotes in this article: TMO, FIT, DG, DLTR, AAPL, AMZN

Cleveland Research's notorious channel checks are moving the markets once again -- this time causing some Fitbit (FIT) shareholders to run for the hills.

The opaque, anti-media, approximately 80-person-strong firm released a note this morning saying it is cautious on Fitbit heading into the fourth quarter -- and into the first quarter of fiscal year 2017. Cleveland Research says new-product uptake is muted and it is concerned about inventory levels, according to TheFly.

And if you thought at the beginning of the trading day that Cleveland Research's influence was waning, since FIT shares had dropped just 1% by 10 a.m., think again. Shares continued to fall, and they were down by nearly 3% during midday trading -- which is almost as substantial as the impact of its takedown on Thermo Fisher Scientific (TMO) in September, or even its most recent action on Dollar General (DG) and its rival Dollar Tree (DLTR) . But given that the firm claims to have 150 of the largest hedge funds and mutual funds as its clients (who pay at least $250,000 annually for the reports), it is easy to understand how this firm from the midwest can command such action in the market.

Sure, Fitbit is in in the midst of a major transition.

CEO James Park told TheStreet's Jim Cramer on Mad Money yesterday that the company is shifting its mission and purpose from simply consumer electronics to become a digital health-care company. Cramer believes that there is "big money" in Fitbit's digital health plans. But Cramer, admittedly, loves the products and the company.

A third-party study announced this week, however, found that employer health-care costs for employees that opted into a Fitbit wellness plan was 25% less than market average, which translated into approximately $1,300 in savings per employee, according to Fitbit.

And as for those channel checks, which Cleveland Research prides itself on, there seems to be growing skepticism around them (especially after so many Apple (AAPL) analysts' channel checks clearly underestimated the demand for the iPhone 7).

As we reported previously, Pacific Crest, another research firm also known for its channel checks, put out a note on Sep. 28 that said the new Fitbit device has too much inventory accumulation. Sounds familiar, right? Well, Park said, in his Mad Money interview yesterday, that the company "just started shipping the product," adding that Fitbit Charge 2 is the number one, best-selling fitness tracker on Amazon (AMZN)  right now. (Amazon is a holding in TheStreet's Growth Seeker portfolio).

So, how can channel checks truly judge demand when the product is just hitting the market and consumers are still learning about it? Sure, they can provide insight, but they won't necessarily reveal the whole picture, as was clearly evident with Apple's iPhone 7 release. (Apple is a holding in Jim Cramer's Action Alerts PLUS portfolio). 

But nonetheless, investors should continue to be aware of Cleveland Research's presence -- especially ahead of earnings season, which is its prime time for putting out notes. As we have seen, a comment from this firm can move the market.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

Action Alerts PLUS, which Cramer co-manages as a charitable trust, is long AAPL stock.

Growth Seeker is long AMZN stock. 

 

TAGS: Investing | U.S. Equity | Technology | Healthcare | Consumer Discretionary | Analyst Actions | Earnings

More from Healthcare

Nuvalent Has Begun the Bottoming Process

Bruce Kamich
Jul 1, 2022 10:52 AM EDT

Let's check the charts and indicators.

CRISPR Therapeutics Has Turned the Corner

Bruce Kamich
Jul 1, 2022 8:43 AM EDT

Here's our current price target.

Johnson & Johnson Appears to Be Running Out of Steam

Bruce Kamich
Jun 22, 2022 8:25 AM EDT

The shares of the healthcare giant have been in a long-term uptrend but could break that trend in the weeks ahead.

Anthem's Long-Term Uptrend Is Losing Its Vigor

Bruce Kamich
Jun 22, 2022 7:40 AM EDT

The technical signals of the health benefits provider are weakening.

Here Are 2 Prudent Healthcare Trades

Bret Jensen
Jun 17, 2022 11:30 AM EDT

The country might be heading into recession, but folks still need to get their medicine, good times or bad.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:59 PM EDT PAUL PRICE

    Very good quarterly numbers from Bassett Furniture (BSET)

    Bassett Furniture (BSET) blew right through analys...
  • 04:41 PM EDT PAUL PRICE

    First Half Results - Putrid Second Half Results - Likely to Be Much Better

    It's great that we're done with June. 2022 marked...
  • 04:51 PM EDT PAUL PRICE

    We Should Be in for Better Starting Soon

    Window dressing Thursday, the last day of the...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login